ImageneBio Inc
- IMA
- NASDAQ
- Biotechnology
- Clinical-Stage Biopharma
- Anti-OX40 Monoclonal Antibody
$4.04
Today +0.25%Quote Oct 16, 2026, 08:00 PM UTC
−19.52%over the last month
Max drawdown −19.7%From 1-month high −19.5%3 months −29.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$45.9M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$1.33
−67.1% from here
Floor
$3.92
3.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IMAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
18